Companion Animal Veterinary Vaccines Market Forecast Highlights A $5.38 Billion Opportunity For Industry Participants
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Companion Animal Veterinary Vaccines Market Forecast: Value Set To Climb From $4.19 Billion To $5.38 Billion
The companion animal veterinary vaccines market has experienced robust growth in recent years. It is projected to expand from $3.94 billion in 2025 to $4.19 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.4%. This historical expansion can be primarily linked to an increasing companion animal population, the rising occurrence of infectious diseases among pets, the expansion of veterinary clinics and hospitals, a greater understanding of the advantages of animal vaccination, and enhancements in cold chain vaccine distribution.
The companion animal veterinary vaccines market is projected to experience robust expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $5.38 billion, demonstrating a compound annual growth rate (CAGR) of 6.5%. This growth during the projected period stems from several factors, including the escalating trend of pet humanization, increased spending on pet healthcare, innovations in vaccine technology, a rise in urban pet ownership, and supportive government initiatives for animal health. Key developments expected in this timeframe encompass the growing embrace of combination vaccines, a heightened emphasis on preventive pet healthcare, broader vaccination coverage for companion animals, the proliferation of recombinant and DNA-based vaccines, and an increasing preference for oral and less intrusive vaccination methods.
Get A Free Sample Report With In-Depth Market Insights:
Companion Animal Veterinary Vaccines Market Demand Drivers Opening New Revenue Streams
The escalating expenditures on pet health are projected to stimulate the expansion of the companion animal veterinary vaccines market in the future. Pet health refers to the comprehensive well-being and physical state of various domesticated animals, including dogs, cats, birds, and small mammals. This increase in pet health spending is occurring because pet owners are becoming more aware of the critical role of preventive care and advanced treatments in ensuring their pets lead longer, healthier lives. The companion animal veterinary vaccines market contributes to this rising spending on pet health by supplying vital vaccines that prevent diseases and reduce long-term veterinary costs, thereby encouraging pet owners to invest further in their pets’ welfare. For instance, in February 2025, a report published by the pet business professor, a US-based government agency, revealed that U.S. pet owners spent approximately $13.42 billion on pet services, an 8.5% rise from $12.36 billion in 2022, indicating sustained growth in grooming, boarding, and general care utilization. Thus, increased spending on pet health is propelling the growth of the companion animal veterinary vaccines market.
Companion Animal Veterinary Vaccines Market Segment Analysis Spotlighting Growth Areas
The companion animal veterinary vaccines market covered in this report is segmented –
1) By Product: Inactivated, Live Attenuated, Recombinant, Other Products
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels
Subsegments:
1) By Inactivated: Inactivated Canine Vaccines, Inactivated Feline Vaccines, Inactivated Vaccine Combinations
2) By Live Attenuated: Live Attenuated Canine Vaccines, Live Attenuated Feline Vaccines, Live Attenuated Vaccine Combinations
3) By Recombinant: Recombinant Canine Vaccines, Recombinant Feline Vaccines, Recombinant Vaccine Combinations
4) By Other Products: DNA Vaccines, Subunit Vaccines, Toxoid Vaccines
Companion Animal Veterinary Vaccines Market Trends Powering Strategic Industry Growth
Leading companies in the companion animal vaccine market are introducing new vaccines, such as recombinant DNA vaccines, with the goal of improving the effectiveness and safety of immunizations for pets. A recombinant DNA vaccine refers to a type of vaccine produced by inserting genetic material (DNA) from a pathogen, like a virus or bacterium, into a harmless organism or vector. For instance, in March 2024, Zendal Group, a Spain-based biotechnology company, launched Neoleish, which is the first recombinant DNA vaccine specifically developed to combat canine leishmaniasis, created in collaboration with the Spanish National Research Council (CSIC). Officially presented at the XLI Annual Congress of the Madrid Association of Veterinarians of Companion Animals, Neoleish has demonstrated over 90% efficacy in reducing the infection risk from the Leishmania infantum parasite.
Companion Animal Veterinary Vaccines Market Industry Leaders And Competitive Landscape
Major companies operating in the companion animal veterinary vaccines market are C.H. Boehringer Sohn AG & Co. KG, Heska Corp., Merck and Co. Inc., Elanco Animal Health, Zoetis Inc., Ceva Sante Animale SA, Vetoquinol SA, Hipra India Pvt Ltd, Bimeda Animal Health Limited, Nexvet Biopharma plc, Laboratorios Hipra SA, Dechra Pharmaceuticals PLC, CZ Veterinaria SA, Virbac, Boehringer Ingelheim Animal Health, Indian Immunologicals Limited, HIPRA SA, IDT Biologika GmbH, Ourofino Saude Animal, Zydus Animal Health, Meiji Seika Pharma Co Ltd, Parnell Pharmaceuticals, Kindred Biosciences Inc, Hester Biosciences Limited
View The Full Companion Animal Veterinary Vaccines Market Report:
Companion Animal Veterinary Vaccines Market Regional Analysis And Leading Geography
North America was the largest region in the companion animal veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the companion animal veterinary vaccines market. The regions covered in the companion animal veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
